Christopher Michael Ryan - 22 May 2024 Form 4 Insider Report for Gevo, Inc. (GEVO)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
24 May 2024, 17:37:59 UTC
Prior SEC filing
25 Aug 2023
Next SEC filing
01 Aug 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ E. Cabell Massey, Attorney-in-Fact

Key filing fact

Christopher Michael Ryan filed Form 4 for Gevo, Inc. (GEVO) on 24 May 2024.

Key facts

  • This page summarizes Christopher Michael Ryan's Form 4 filing for Gevo, Inc. (GEVO).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 24 May 2024, 17:37.

Change

  • Previous filing in this sequence was filed on 25 Aug 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GEVO transaction

Common Stock

Award

Transaction value
$0
Shares
+550,000
Change %
+46%
Price
$0.000000
Shares after
1,744,377
Date
22 May 2024
Ownership
Direct
Footnotes
F1
GEVO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
26,942
Date
22 May 2024
Ownership
By 401(k) Plan
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GEVO transaction Derivative

Stock Option

Award

Transaction value
$0
Shares
+550,000
Change %
Price
$0.000000
Shares after
550,000
Date
22 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
550,000
Exercise price
$0.7100
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents restricted common stock that vests in three equal annual installments beginning on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Footnote F2

Between January 1 and May 22, 2024, the reporting person acquired 26,942.43 shares of the issuer's common stock under the issuer's 401(k) plan. The information in this report is based on a plan statement dated May 22, 2024.

Footnote F3

The stock options shall vest in three equal annual installments beginning on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer as of each vesting date; provided, further, that any vested portion of such option shall only be exercisable by the reporting person if the daily volume weighted average price of the issuer's common stock during any 20 consecutive trading day period after the grant date and prior to May 21, 2034 equals or exceeds $1.00.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .